经口胰管镜在胰管内疾病诊疗中的应用分析(含视频)

Application of peroral pancreatoscope in the diagnosis and treatment of pancreatic duct diseases (with video)

摘要:

回顾性分析南京医科大学第一附属医院胰腺中心2020年8月—2022年10月收治的23例因考虑胰管内疾病行经口胰管镜检查的患者资料，分析术中所见、术后并发症情况及胰管镜对胰管疾病的诊疗价值。所有患者接受胰管镜检查，并达到技术成功。其中7例患者确诊为胰腺导管内乳头状黏液性肿瘤，3例确诊为胰腺恶性肿瘤，8例胰管结石患者在胰管镜下行激光或液电碎石术，2例慢性胰腺炎患者经治疗后腹痛好转，2例胰管内出血和胰肠吻合口炎症患者经保守治疗后黑便消失，1例胰肠吻合口狭窄患者经球囊扩张后症状改善。23例患者均未出现手术并发症，手术操作时间为35~90 min。经口胰管镜在胰管内疾病的诊疗中安全有效，且有独特的优势。

Abstract:

A retrospective study was conducted on data of 23 patients with pancreatic duct diseases who were underwent peroral pancreatoscopy (POPS) at the Pancreatic Center of the First Affiliated Hospital of Nanjing Medical University from August 2020 to October 2022. The intraoperative observation, postoperative complications, and the diagnosis and treatment of POPS for pancreatic duct diseases were analyzed. All patients underwent POPS and achieved technical success. Among them, 7 patients were diagnosed as having intraductal papillary mucinous neoplasm of pancreas and 3 pancreatic malignant tumor. Eight patients with pancreatolithiasis accepted laser or eletrohydraulic lithotripsy under POPS. Abdominal pain improved in 2 patients with chronic pancreatitis after treatment. Melena disappeared in 2 patients with pancreatic duct hemorrhage or pancreatic enterostomy inflammation after conservative treatment. The symptom of 1 patient with pancreatic enterostomy stenosis improved after balloon dilation. There was no complication in the 23 patients, and the operation time was 35‑90 min. The results indicate POPS is safe, effective with distinctive advantages in the diagnosis and treatment for pancreatic duct diseases.